Business ❯ Biotechnology ❯ Pharmaceuticals
Clinical Trials Antibody-Drug Conjugates Obesity Treatments AI in Drug Discovery Autoimmune Diseases Clinical Research Oncology Licensing Agreements Genetically Modified Organisms Eli Lilly and Company Celltrion New Drug Application siRNA Therapies Muscular Dystrophy Functional Cell Lines Acquisitions mRNA Technology Antibody Therapeutics Multiple Sclerosis Genmab Kidney Diseases Cystic Fibrosis Treatment T Cell Engagers Regulatory Approval AI in Pharmaceuticals Drug-Fc Conjugates Bispecific Antibodies Partnership Strategies Antibodies Summit Therapeutics Cystic Fibrosis Immunology Rare Diseases Protein Therapeutics CAR-T Therapy Cardiovascular Therapeutics Acquisition Oral Therapies Anti-IgE Therapy FDA Leadership Cell Therapy Contract Manufacturing Allergy Therapeutics Psilocybin Treatments Generative AI Alzheimer's Treatment Regulatory Affairs Efficacy and Safety Results Research Collaboration Vepdegestrant FDA Approvals Clinical Efficacy TN-201 Gene Therapy
Want to see what podcasts are saying about this topic? Search across 120K+ podcasts. Explore Radar
The purchase brings an oral once‑daily acromegaly pill and a late‑stage ACTH candidate to Vertex, signaling a strategic push beyond its cystic fibrosis business.
